<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336615">
  <stage>Registered</stage>
  <submitdate>19/08/2011</submitdate>
  <approvaldate>30/08/2011</approvaldate>
  <actrnumber>ACTRN12611000931976</actrnumber>
  <trial_identification>
    <studytitle>Telmisartan in the management of abdominal aortic aneurysm</studytitle>
    <scientifictitle>The effects of Telmisartan, an angiotensinII type 1 receptor blocker, in reducing AAA growth in patients with abdominal aortic aneurysm.</scientifictitle>
    <utrn>U1111-1119-8488</utrn>
    <trialacronym>TEDY</trialacronym>
    <secondaryid>ClinicalTrials.gov: NCT01683084</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Abdominal Aortic Aneurysm</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Angiotensin II type 1 receptor blocker, oral tablet, 40mg daily for 24 months.</interventions>
    <comparator>Placebo, sugar pill that is identical in appearance to Telmisartan but without the active ingredient.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in AAA growth as measured by 1) maximum diameter on ultrasound, and/or 2) maximum orthogonal diameter on computed tomographic angiography and/or 3) maximum infra-renal aortic volume on computed tomographic angiography.</outcome>
      <timepoint>Computed tomographic angiography conducted at entry, 12 and 24 months (conducted at entry and 24 months only at Leiden and Stanford study centres). Ultrasound measurement conducted at entry, 6, 12, 18 and 24 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in resting brachial blood pressure measured with sphygmomanometer</outcome>
      <timepoint>Resting blood pressure to be measured at entry, 3, 6, 12, 18 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>SF36 quality of life questionnaire.</outcome>
      <timepoint>SF-36 questionnaires to be collected at entry, 12 and 24 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>AAA biomarker concentrations.</outcome>
      <timepoint>Blood collection (SST tubes x 2, EDTA tubes x 2, Citrate tube x 1, PaxGene tube x 1) to be undertaken at entry, 6, 12, 18 and 24 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Written informed consent 2. Infra-renal AAA measuring a maximum orthogonal diameter greater than or equal to 35mm and less than or equal to 49mm on CTA or ultrasound; 3. Stable medication regime for the last 6 months; 4. No current indication for AAA repair according to the treating physician or expectation that this will be revised within the next year; 5. High likelihood of compliance with treatment over 24 months.</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications to study treatment, including: 1. renal impairment (i.e. creatinine &gt;1.5x upper limit of normal [ULN]), 2. known significant renal stenosis (&gt;70%) of one or both renal arteries, 3. chronic liver disease (i.e. cirrhosis or hepatitis) or abnormal liver function (i.e. ALT 1.5xULN), 4. electrolyte imbalance and 5. active gout; 6. Current or planned usage of an AT1 blocker 7. Current or planned usage of an ACE inhibitor. 8. If the patient has previously had abdominal aortic surgery</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients will be randomised by a blinded health professional through the secure trial website, coordinated by an independent trial centre. Random number sequences will correspond to serial numbers on concealed study packaging.</concealment>
    <sequence>Stratified randomisation by the online randomisation website (ccre.med.monash.edu.au/TEDYrand). </sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Nil</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>5/09/2011</anticipatedstartdate>
    <actualstartdate>9/09/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>NSW,QLD,SA,WA,VIC</recruitmentstate>
    <hospital>Mackay Base Hospital - Mackay</hospital>
    <postcode>3128 - Box Hill</postcode>
    <postcode>2250 - Gosford</postcode>
    <postcode>5011 - Woodville South</postcode>
    <postcode>4740 - Mackay</postcode>
    <postcode>3181 - Prahran</postcode>
    <postcode>4029 - Royal Brisbane Hospital</postcode>
    <postcode>4811 - James Cook University</postcode>
    <postcode>4812 - Pimlico</postcode>
    <postcode>4814 - Douglas</postcode>
    <postcode>6160 - Fremantle</postcode>
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Leiden</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>James Cook University</primarysponsorname>
    <primarysponsoraddress>James Cook Drive
Douglas, Townsville
Queensland 4811</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>BUPA</fundingname>
      <fundingaddress>Bupa Australia
600 Glenferrie Rd
Hawthorn
Victoria
3122</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress>Level 1
16 Marcus Clarke Street
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Queensland Health</fundingname>
      <fundingaddress>Queensland Health
147-163 Charlotte Street
Brisbane Queensland 4000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Townsville Hospital</othercollaboratorname>
      <othercollaboratoraddress>100 Angus Smith Dr,
Douglas QLD 4814</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Mater Health Services NQ Ltd</othercollaboratorname>
      <othercollaboratoraddress>21-37 Fulham Rd,
Pimlico
Queensland QLD 4812</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Royal Brisbane Women's Hospital</othercollaboratorname>
      <othercollaboratoraddress>Cnr Butterfield and Bowen Bridge Rd
Brisbane
Queensland 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Fremantle Hospital</othercollaboratorname>
      <othercollaboratoraddress>Alma St,
Fremantle 
Western Australia 6959</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Alfred Hospital</othercollaboratorname>
      <othercollaboratoraddress>Commercial Road
Prahran
Victoria 3181</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>The Queen Elizbeth Hospital</othercollaboratorname>
      <othercollaboratoraddress>28 Woodville Road, 
Woodville South, 
SA 5011 AUSTRALIA
</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>Gosford Vascular Services</othercollaboratorname>
      <othercollaboratoraddress>213 Albany St
Gosford
NSW 2250</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Box Hill Hospital</othercollaboratorname>
      <othercollaboratoraddress>Nelson Rd, Box Hill 
VIC 3128</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Leiden University Medical Center</othercollaboratorname>
      <othercollaboratoraddress>Leiden University Medical Center
Albinusdreef 2
2333 ZA Leiden, Netherlands</othercollaboratoraddress>
      <othercollaboratorcountry>Netherlands</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Veterans Administration Hospital &amp; Stanford University
</othercollaboratorname>
      <othercollaboratoraddress>3801 Miranda Ave
Palo Alto CA 94304, United States</othercollaboratoraddress>
      <othercollaboratorcountry>United States of America</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Mackay Base Hospital</othercollaboratorname>
      <othercollaboratoraddress>475 Bridge Road
West Mackay</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to investigate telmisartan as a novel therapy for patients with abdominal aortic aneurysms. We hypothesize that telmisartan will reduce AAA growth.</summary>
    <trialwebsite>http://ncre-pad.registry.org.au/clinical-studies/current-studies/lists/current-ncre-pad-studies/tedy
https://ccre.med.monash.edu.au/TedyRand/</trialwebsite>
    <publication>TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
Dylan R. Morris, Margaret A. Cunningham, Anna A. Ahimastos, Bronwyn A. Kingwell, Elise Pappas, Michael Bourke, Christopher M. Reid, Theo Stijnen, Ronald L. Dalman, Oliver O. Aalami, Jan H. Lindeman, Paul E. Norman, Philip J. Walker, Robert Fitridge, Bernie Bourke, Anthony E. Dear, Jenna Pinchbeck, Rene Jaeggi and Jonathan GolledgeEmail author
Contributed equally
Trials 201516:274
DOI: 10.1186/s13063-015-0793-zÂ©  Morris et al. 2016
Received: 17 March 2015 Accepted: 2 June 2015 Published: 17 June 2015</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Townsville Health Service District</ethicname>
      <ethicaddress>100 Angus Smith Dr
Douglas QLD 4814</ethicaddress>
      <ethicapprovaldate>12/04/2010</ethicapprovaldate>
      <hrec>HREC/09/QTHS/117</hrec>
      <ethicsubmitdate>8/01/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>JCU Human Research Ethics Committee</ethicname>
      <ethicaddress>Douglas, Townsville
QLD 4811</ethicaddress>
      <ethicapprovaldate>12/04/2010</ethicapprovaldate>
      <hrec>C7</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Mater Health Services NQ Ltd</ethicname>
      <ethicaddress>21-37 Fulham Rd
Pimlico, Townsville
QLD 4812</ethicaddress>
      <ethicapprovaldate>21/09/2010</ethicapprovaldate>
      <hrec>EC00412</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Alfred Hospital Ethics Committee</ethicname>
      <ethicaddress>Commercial Road,
Melbourne
VIC 3181</ethicaddress>
      <ethicapprovaldate>20/05/2010</ethicapprovaldate>
      <hrec>23/10/2010</hrec>
      <ethicsubmitdate>25/02/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital Metro North Health Service District</ethicname>
      <ethicaddress>Cnr Butterfield &amp; Bowen Bridge Rd
Herston
QLD 4029</ethicaddress>
      <ethicapprovaldate>23/06/2010</ethicapprovaldate>
      <hrec>HREC/10/WRBW/28</hrec>
      <ethicsubmitdate>8/01/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Government of Western Australia Department of Health South Metropolitan Area Health Service</ethicname>
      <ethicaddress>Alma St
Fremantle
WA 6959</ethicaddress>
      <ethicapprovaldate>24/08/2010</ethicapprovaldate>
      <hrec>1/10/0317</hrec>
      <ethicsubmitdate>10/08/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Jonathan Golledge</name>
      <address>School of Medicine
Vascular Biology Unit
James Cook University
Townsville, QLD 4811</address>
      <phone>+61 7 47814730</phone>
      <fax>+61 7 4781 3652</fax>
      <email>jonathan.golledge@jcu.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Leonie Jones</name>
      <address>School of Medicine
Vascular Biology Unit
James Cook University
Townsville, QLD 4811</address>
      <phone>+61 7 47814276</phone>
      <fax>+61 7 4781 3652</fax>
      <email>leonie.jones@jcu.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Leonie Jones</name>
      <address>School of Medicine
Vascular Biology Unit
James Cook University
Townsville, QLD 4811</address>
      <phone>+61 7 47814276</phone>
      <fax>+61 7 47813652</fax>
      <email>leonie.jones@jcu.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jonathan Golledge</name>
      <address>James Cook University
James Cook Drive
Townsville 4811
QLD</address>
      <phone>+61 7 4433 1443</phone>
      <fax>+61 7 4433 1401</fax>
      <email>jonathan.golledge@jcu.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>